APA (7th ed.) Citation

JY, C., JW, L., SW, F., YJ, H., SW, L., TY, H., & FC, L. (2024). Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells. In vivo (Athens, Greece), 38(6), 3131. https://doi.org/10.21873/invivo.13799

Chicago Style (17th ed.) Citation

JY, Chen, Lu JW, Feng SW, Ho YJ, Lui SW, Hsieh TY, and Liu FC. "Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells." In Vivo (Athens, Greece) 38, no. 6 (2024): 3131. https://doi.org/10.21873/invivo.13799.

MLA (9th ed.) Citation

JY, Chen, et al. "Molecular Hydrogen Therapy in Aneurysmal SAH With RA and Newly-diagnosed SLE, Complicated With Acute Ischemic Infarction: A Case Report of Improved Immune Markers Including Tr1 Cells, Breg Cells and TIM3 Expression on Tc Cells." In Vivo (Athens, Greece), vol. 38, no. 6, 2024, p. 3131, https://doi.org/10.21873/invivo.13799.